Literature DB >> 10027832

Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate.

S Taverna1, G Sancini, M Mantegazza, S Franceschetti, G Avanzini.   

Abstract

The actions of the antiepileptic drug topiramate (TPM) on Na+ currents were assessed using whole-cell patch-clamp recordings in dissociated neocortical neurons and intracellular recordings in neocortical slices. Relatively low TPM concentrations (25-30 microM) slightly inhibited the persistent fraction of Na+ current in dissociated neurons and reduced the Na+-dependent long-lasting action potential shoulders, which can be evoked in layer V pyramidal neurons after Ca++ and K+ current blockade. Conversely, the same drug concentrations were ineffective in reducing the amplitude of the fast Na+-dependent action potentials evoked in slices or the peak of transient Na+ (INaf) current evoked in isolated neurons from a physiological holding potential. Consistent INaf inhibition became, however, evident only when the neuronal membrane was kept depolarized to enhance resting Na+ channel inactivation. TPM (100 microM) was ineffective on the voltage dependence of activation but induced a leftward shift of the steady-state INaf inactivation curve. The drug-induced inhibitory effect increased with the duration of membrane depolarization, and the recovery of INaf after long membrane depolarizations was slightly delayed in comparison with that observed under control conditions. The obtained evidence suggests that the anticonvulsant action of TPM may operate by stabilizing channel inactivation, which can be induced by depolarizing events similar to those occurring in chronic epileptic conditions. Concurrently, the slight but significant inhibition of the persistent fraction of the Na+ current, obtained with the application of relatively low TPM concentrations, may contribute toward its anticonvulsant effectiveness by modulating the near-threshold depolarizing events that are sustained by this small current fraction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027832

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

1.  Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.

Authors:  M Inghilleri; A Conte; V Frasca; A Curra'; F Gilio; M Manfredi; A Berardelli
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

2.  Post-spike distance-to-threshold trajectories of neurones in monkey motor cortex.

Authors:  Daniel Z Wetmore; Stuart N Baker
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

3.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 6.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

7.  A riluzole- and valproate-sensitive persistent sodium current contributes to the resting membrane potential and increases the excitability of sympathetic neurones.

Authors:  J Antonio Lamas; Marcos Romero; Antonio Reboreda; Estela Sánchez; Sandro J Ribeiro
Journal:  Pflugers Arch       Date:  2009-02-21       Impact factor: 3.657

8.  Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current.

Authors:  G Curia; P Aracri; E Colombo; P Scalmani; M Mantegazza; G Avanzini; S Franceschetti
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

9.  Topiramate and cortical excitability in humans: a study with repetitive transcranial magnetic stimulation.

Authors:  M Inghilleri; F Gilio; A Conte; V Frasca; C Marini Bettolo; E Iacovelli; B Gregori; M Prencipe; A Berardelli
Journal:  Exp Brain Res       Date:  2006-08-05       Impact factor: 1.972

Review 10.  Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

Authors:  Bankole A Johnson; Nassima Ait-Daoud
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.